Selected research
Industry Research
Recombinant Protein Service Industry Research Report 2026
Market perspective
The global Recombinant Protein Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Recombinant Protein Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Recombinant Protein Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Recombinant Protein Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Recombinant Protein Service include Sino Biological, Boster Bio, Proteos, ImmunoDiagnostics Limited, BiologicsCorp, GenScript, OriGene Technologies, R＆D Systems and Biomiga, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Recombinant Protein Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Recombinant Protein Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Recombinant Protein Service Market by Company
Sino Biological
Boster Bio
Proteos
ImmunoDiagnostics Limited
BiologicsCorp
GenScript
OriGene Technologies
R＆D Systems
Biomiga
Genemed
RayBiotech
BioServUK
Elabscienc
Jubilant Biosys
Recombinant Protein Service Segment by Type
Protein Purification
Protein Expression
Protein Modification And Processing
Other
Recombinant Protein Service Segment by Application
Antibody Production
Vaccine Production
Protein Pharmaceutical Production
Other
Recombinant Protein Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Protein Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Protein Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Protein Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Recombinant Protein Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Protein Purification
- Protein Expression
- Protein Modification And Processing
- Other
Applications
- Antibody Production
- Vaccine Production
- Protein Pharmaceutical Production
- Other
Companies covered
- Sino Biological
- Boster Bio
- Proteos
- ImmunoDiagnostics Limited
- BiologicsCorp
- GenScript
- OriGene Technologies
- R＆D Systems
- Biomiga
- Genemed
- RayBiotech
- BioServUK
- Elabscienc
- Jubilant Biosys
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Recombinant Protein Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Protein Purification
- 2.2.3 Protein Expression
- 2.2.4 Protein Modification And Processing
- 2.2.5 Other
- 2.3 Recombinant Protein Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Antibody Production
- 2.3.3 Vaccine Production
- 2.3.4 Protein Pharmaceutical Production
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Recombinant Protein Service Breakdown Data by Type
- 3.1 Global Recombinant Protein Service Historic Market Size by Type (2021-2026)
- 3.2 Global Recombinant Protein Service Forecasted Market Size by Type (2027-2032)
4 Recombinant Protein Service Breakdown Data by Application
- 4.1 Global Recombinant Protein Service Historic Market Size by Application (2021-2026)
- 4.2 Global Recombinant Protein Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Recombinant Protein Service Market Perspective (2021-2032)
- 5.2 Global Recombinant Protein Service Growth Trends by Region
- 5.2.1 Global Recombinant Protein Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Recombinant Protein Service Historic Market Size by Region (2021-2026)
- 5.2.3 Recombinant Protein Service Forecasted Market Size by Region (2027-2032)
- 5.3 Recombinant Protein Service Market Dynamics
- 5.3.1 Recombinant Protein Service Industry Trends
- 5.3.2 Recombinant Protein Service Market Drivers
- 5.3.3 Recombinant Protein Service Market Challenges
- 5.3.4 Recombinant Protein Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Recombinant Protein Service Players by Revenue
- 6.1.1 Global Top Recombinant Protein Service Players by Revenue (2021-2026)
- 6.1.2 Global Recombinant Protein Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Recombinant Protein Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Recombinant Protein Service Head Office and Area Served
- 6.4 Global Recombinant Protein Service Players, Product Type & Application
- 6.5 Global Recombinant Protein Service Manufacturers Established Date
- 6.6 Global Recombinant Protein Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Recombinant Protein Service Market Size (2021-2032)
- 7.2 North America Recombinant Protein Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Recombinant Protein Service Market Size by Country (2021-2026)
- 7.4 North America Recombinant Protein Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Recombinant Protein Service Market Size (2021-2032)
- 8.2 Europe Recombinant Protein Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Recombinant Protein Service Market Size by Country (2021-2026)
- 8.4 Europe Recombinant Protein Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Recombinant Protein Service Market Size (2021-2032)
- 9.2 Asia-Pacific Recombinant Protein Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Recombinant Protein Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Recombinant Protein Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Recombinant Protein Service Market Size (2021-2032)
- 10.2 South America Recombinant Protein Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Recombinant Protein Service Market Size by Country (2021-2026)
- 10.4 South America Recombinant Protein Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Recombinant Protein Service Market Size (2021-2032)
- 11.2 Middle East & Africa Recombinant Protein Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Recombinant Protein Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Recombinant Protein Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Sino Biological
- 12.1.1 Sino Biological Company Information
- 12.1.2 Sino Biological Business Overview
- 12.1.3 Sino Biological Revenue in Recombinant Protein Service Business (2021-2026)
- 12.1.4 Sino Biological Recombinant Protein Service Product Portfolio
- 12.1.5 Sino Biological Recent Developments
- 12.2 Boster Bio
- 12.2.1 Boster Bio Company Information
- 12.2.2 Boster Bio Business Overview
- 12.2.3 Boster Bio Revenue in Recombinant Protein Service Business (2021-2026)
- 12.2.4 Boster Bio Recombinant Protein Service Product Portfolio
- 12.2.5 Boster Bio Recent Developments
- 12.3 Proteos
- 12.3.1 Proteos Company Information
- 12.3.2 Proteos Business Overview
- 12.3.3 Proteos Revenue in Recombinant Protein Service Business (2021-2026)
- 12.3.4 Proteos Recombinant Protein Service Product Portfolio
- 12.3.5 Proteos Recent Developments
- 12.4 ImmunoDiagnostics Limited
- 12.4.1 ImmunoDiagnostics Limited Company Information
- 12.4.2 ImmunoDiagnostics Limited Business Overview
- 12.4.3 ImmunoDiagnostics Limited Revenue in Recombinant Protein Service Business (2021-2026)
- 12.4.4 ImmunoDiagnostics Limited Recombinant Protein Service Product Portfolio
- 12.4.5 ImmunoDiagnostics Limited Recent Developments
- 12.5 BiologicsCorp
- 12.5.1 BiologicsCorp Company Information
- 12.5.2 BiologicsCorp Business Overview
- 12.5.3 BiologicsCorp Revenue in Recombinant Protein Service Business (2021-2026)
- 12.5.4 BiologicsCorp Recombinant Protein Service Product Portfolio
- 12.5.5 BiologicsCorp Recent Developments
- 12.6 GenScript
- 12.6.1 GenScript Company Information
- 12.6.2 GenScript Business Overview
- 12.6.3 GenScript Revenue in Recombinant Protein Service Business (2021-2026)
- 12.6.4 GenScript Recombinant Protein Service Product Portfolio
- 12.6.5 GenScript Recent Developments
- 12.7 OriGene Technologies
- 12.7.1 OriGene Technologies Company Information
- 12.7.2 OriGene Technologies Business Overview
- 12.7.3 OriGene Technologies Revenue in Recombinant Protein Service Business (2021-2026)
- 12.7.4 OriGene Technologies Recombinant Protein Service Product Portfolio
- 12.7.5 OriGene Technologies Recent Developments
- 12.8 R＆D Systems
- 12.8.1 R＆D Systems Company Information
- 12.8.2 R＆D Systems Business Overview
- 12.8.3 R＆D Systems Revenue in Recombinant Protein Service Business (2021-2026)
- 12.8.4 R＆D Systems Recombinant Protein Service Product Portfolio
- 12.8.5 R＆D Systems Recent Developments
- 12.9 Biomiga
- 12.9.1 Biomiga Company Information
- 12.9.2 Biomiga Business Overview
- 12.9.3 Biomiga Revenue in Recombinant Protein Service Business (2021-2026)
- 12.9.4 Biomiga Recombinant Protein Service Product Portfolio
- 12.9.5 Biomiga Recent Developments
- 12.10 Genemed
- 12.10.1 Genemed Company Information
- 12.10.2 Genemed Business Overview
- 12.10.3 Genemed Revenue in Recombinant Protein Service Business (2021-2026)
- 12.10.4 Genemed Recombinant Protein Service Product Portfolio
- 12.10.5 Genemed Recent Developments
- 12.11 RayBiotech
- 12.11.1 RayBiotech Company Information
- 12.11.2 RayBiotech Business Overview
- 12.11.3 RayBiotech Revenue in Recombinant Protein Service Business (2021-2026)
- 12.11.4 RayBiotech Recombinant Protein Service Product Portfolio
- 12.11.5 RayBiotech Recent Developments
- 12.12 BioServUK
- 12.12.1 BioServUK Company Information
- 12.12.2 BioServUK Business Overview
- 12.12.3 BioServUK Revenue in Recombinant Protein Service Business (2021-2026)
- 12.12.4 BioServUK Recombinant Protein Service Product Portfolio
- 12.12.5 BioServUK Recent Developments
- 12.13 Elabscienc
- 12.13.1 Elabscienc Company Information
- 12.13.2 Elabscienc Business Overview
- 12.13.3 Elabscienc Revenue in Recombinant Protein Service Business (2021-2026)
- 12.13.4 Elabscienc Recombinant Protein Service Product Portfolio
- 12.13.5 Elabscienc Recent Developments
- 12.14 Jubilant Biosys
- 12.14.1 Jubilant Biosys Company Information
- 12.14.2 Jubilant Biosys Business Overview
- 12.14.3 Jubilant Biosys Revenue in Recombinant Protein Service Business (2021-2026)
- 12.14.4 Jubilant Biosys Recombinant Protein Service Product Portfolio
- 12.14.5 Jubilant Biosys Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst